All Pharma News
price-trendAsk Us
Canadian company hopes to take psychedelic therapy mainstream

Canadian company hopes to take psychedelic therapy mainstream
Sharon Klahr Coey FIERCE PHARMA
24 Jan 2023
Share Share
Novamind Shareholders Approve Proposed Acquisition by Numinus

Novamind Shareholders Approve Proposed Acquisition by Numinus
ACCESSWIRE
08 Jun 2022
Share Share
Numinus to Acquire Novamind

Numinus to Acquire Novamind
ACCESSWIRE
12 Apr 2022
Share Share
Numinus seeks Health Canada approval to start psychedelic product trial

Numinus seeks Health Canada approval to start psychedelic product trial
CLINICALTRIALSARENA
17 Jan 2022
Share Share
Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD

Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD
PRNEWSWIRE
10 Nov 2021
Share Share
Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange

Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange
PRNEWSWIRE
18 Jun 2021
Share Share